search
cancer treatment
Trends
- 1Missing Y chromosome pieces found to drive cancer in menโStudy shows how missing pieces of Y chromosome drive cancer in men
A new study shows how loss of parts of the Y chromosome, a common age-related change in men's cells, can promote cancer growth. Researchers report the missing pieces help tumours evade immune defences, offering a possible explanation for why some cancers in men are more aggressive and opening paths to new treatments.
- 2Physicists help explain how tumor DNA loops drive cancerโผTheoretical physics helps uncover the molecular mechanisms of extrachromosomal DNA in tumors
Researchers at the University of Naples Federico II report that theoretical physics methods have helped reveal the molecular mechanisms governing extrachromosomal DNA in tumors. These circular DNA fragments, separate from chromosomes, are known to promote cancer growth and drug resistance. The study applies physical modelling to understand their behavior, potentially opening new avenues for cancer research and treatment strategies.
- 3
Researchers report that biological features of prostate tumours can help determine which patients are most likely to benefit from hormone therapy. By profiling tumour biology, doctors may be able to better target treatment and avoid giving hormone therapy to those unlikely to respond, a step toward more personalised prostate cancer care.
- 413-Year-Old Cured of DIPG, the Deadliest Childhood Brain CancerโA 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer
A 13-year-old child has reportedly been cured of DIPG, diffuse intrinsic pontine glioma, an aggressive brainstem cancer that has almost always been fatal in children. The case is being described as a world first, and it is drawing wide attention because DIPG has resisted decades of treatment efforts, with most children surviving less than a year after diagnosis. Families, researchers and clinicians are watching closely for confirmation and details of the treatment used.
- 5Penn Medicine and IBA Launch Global Proton Therapy VentureโPenn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
Penn Medicine and Belgian proton therapy company IBA have announced a joint venture to support the development of proton therapy and radiation oncology programs worldwide. The partnership aims to help hospitals and clinics internationally establish and expand advanced cancer treatment services, combining Penn Medicine's clinical expertise with IBA's technology. The announcement has been picked up by financial and international news outlets.
- 6IBA and Penn Medicine Launch Noventra Oncology AllianceโIBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
IBA and Penn Medicine have announced a joint venture called the Noventra Oncology Alliance, combining the particle therapy technology company's expertise with the academic medical center's clinical and research capabilities. The partnership is aimed at advancing cancer treatment, though further details about its scope, funding and first projects have not yet been made widely available.